CMC Asset Lead, Nephrology at Biogen | USA | Rezi

CMC Asset Lead, Nephrology at Biogen

CMC Asset Lead, Nephrology

Biogen · USA

2 weeks ago

CMC Asset Lead, Nephrology

Biogen · USA

18 days ago
Resume preview

Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now

About the Role

As the CMC Asset Lead, you will be an integral part of the PO&T Nephrology team, focusing on the development and launch of Biogen's nephrology assets. Your initial focus will be on overseeing a critical asset in clinical development for multiple indications, including three Phase 3 studies. The successful commercialization of this asset between 2028-2030 is pivotal to Biogen’s growth. In this role, you'll manage various aspects of asset strategy, launch planning, life cycle management, and project financials. Your efforts will directly contribute to the advancement of Biogen's portfolio in nephrology, ensuring alignment with business objectives and collaboration across various stakeholders. Your position within the organization allows you to steer complex, dynamic projects that are essential for the company's strategic goals.

Responsibilities

  • Develop and maintain a 5-year PO&T Asset Strategy and an 18-month rolling Tactical Plan.
  • Lead the cross-functional Asset Team to deliver on strategic objectives.
  • Manage financial accountability, including AOP and FTE allocations, and monitor impacts on the P&L.
  • Develop business cases for key initiatives and secure management endorsement.
  • Proactively resolve conflicts related to Asset Strategy in consultation with governance boards.
  • Serve as the PO&T representative on commercial or development teams, influencing strategic decisions.
  • Collaborate with PO&T and other stakeholders to align asset development with business objectives.
  • Oversee asset planning and execution for late-stage activities and launch.
  • Conduct asset scenario planning and evaluation for development, launch, and life cycle management.

Requirements

  • BS or equivalent in Sciences/Engineering with an advanced degree (MS, PhD, MBA) in a relevant biopharmaceutical discipline preferred.
  • Minimum of 12 years of experience with a focus on matrix management.
  • Proven track record in matrix leadership across program teams and the full product life cycle, including experience in commercial launch.
  • Experience in alliance management, preferably global, and understanding of business contracts.
  • Expertise in CMC, supply chain, or life cycle management development, from IND to NDA/BLA.
  • Strong strategic, organizational, and relationship development skills.
  • Ability to lead and influence strategic direction, leveraging diverse team perspectives.
  • Excellent communication, negotiation, problem-solving, and decision-making abilities.
  • Demonstrated ability to identify critical program risks and develop mitigation strategies.
  • Experience in healthcare, biotech, or pharmaceutical industries with cross-functional interdependencies.
  • Strategic political skills with the ability to navigate complex organizational structures.
  • Technical expertise in biopharmaceutical development disciplines.

Skills

  • Matrix management
  • Matrix leadership
  • Commercial launch
  • Alliance management
  • Business contracts
  • CMC
  • Supply chain
  • Life cycle management
  • Strategic planning
  • Organizational skills
  • Relationship development
  • Influencing strategic direction
  • Communication
  • Negotiation
  • Problem-solving
  • Decision-making
  • Risk identification
  • Mitigation strategies
  • Biopharmaceutical development

Location

  • RTP, NC
  • Cambridge, MA
  • San Francisco, CA

Work Type

  • Hybrid

Experience Level

  • Management
  • 12 years of experience

Education Level

  • BS or equivalent in Sciences/Engineering
  • Advanced degree (MS, PhD, MBA) in a relevant biopharmaceutical discipline preferred

Salary/Compensations

  • $204,000.00-$281,000.00

Benefits

  • Short term and long-term incentives
  • Cash bonus
  • Equity incentive opportunities
  • Medical, Dental, Vision, & Life insurances
  • Fitness & Wellness programs including a fitness reimbursement
  • Short- and Long-Term Disability insurance
  • 15 days of paid vacation
  • End-of-year shutdown time off (Dec 26-Dec 31)
  • 12 company paid holidays
  • 3 paid days off for Personal Significance
  • 80 hours of sick time per calendar year
  • Paid Maternity and Parental Leave benefit
  • 401(k) program participation with company matched contributions
  • Employee stock purchase plan
  • Tuition reimbursement of up to $10,000 per calendar year
  • Employee Resource Groups participation

About the Company

  • We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
  • At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about Biogen.

Equal Opportunity

  • All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.